Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials. Smith TJ, Cavida D, Hsu K, Kim S, et al. Ophthalmology 2024;131:815-826.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith TJ, Cavida D, Hsu K, Kim S, et al. Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials. Ophthalmology 2024;131:815-826.
PMID: 38253291